Current development and challenges of NK cell-based immunotherapy for gastrointestinal cancers
{{output}}
Despite multimodal treatment options, most gastrointestinal (GI) cancers remain associated with high mortality rates and poor responsiveness to immunotherapy. The remarkable success of immune cell-based therapies in hematologic malignancies has raised interest... ...
